Fuji Seal International, Inc. · TSE:7864
Fuji Seal International — Q1 FY2023 Earnings Presentation
26 slides from Fuji Seal International's earnings presentation, Aug 9, 2023
Slide 1: FY2023 First Quarter Financial Results Supplementary Briefing Materials
FY2023 First Quarter Financial Results Supplementary Briefing Materials Fuji Seal International, Inc. August 9, 2023 Copyright 2023 Fuji Seal Group
Slide 2: Table of Contents
Table of Contents 1. Financial Results for the First Quarter of FY 2023 2. Shift to management based on cost of capital 3. Initiative for Sustainable Growth ・New model plant to support sustainable growth ・Expansion of pharmaceutical business 4. First Quarter Topics ・Integrated Report 2023 ・Environme
Slide 3: Key Points of FY2023 1Q Financial Results and Progress toward Full-Year Forecasts
Key Points of FY2023 1Q Financial Results and Progress toward Full-Year Earnings Forecasts ⚫ Sales increase year-on-year, in particular, ordinary profits and net income increased substantially. ⚫ Compared to the full-year announced figures, sales and operating profits are generally in line. FY2022 F
Slide 4: FY2023 1Q Financial Results (1) Net Sales by Region
FY2023 1Q Financial Results (1) Net Sales by Region ⚫ Consolidated net sales increase year-on-year, but net sales increased slightly excluding the impact of foreign exchange. By region, sales increased in Japan and decreased in all other regions excluding the impact of foreign exchange. ～ FY2022 FY2
Slide 5: FY2023 1Q Financial Results (2) Net Sales by Segment by Region
FY2023 1Q Financial Results (2) Net Sales by Segment by Region FY2022 FY2023 Year-on-year change Excluding forex ●Shrink Sleeve Labels: Sales increased due to recovery (Millions of yen) 1st quarter 1st quarter Change Rate of change impact from the impact of Corona and strong performance of Rate of c
Slide 6: FY2023 1Q Financial Results (3) Operating Profits by Region
FY2023 1Q Financial Results (3) Operating Profits by Region FY2022 FY2023 Year-on- ●Shrink Sleeve Labels: At the same level as previous (Millions of yen) 1st quarter Excluding forex impact year due to the effect of price revisions despite the 1st quarter year change continued rise in utility and oth
Slide 7: FY2023 1Q Financial Results (4) Non-operating Income (Expenses), Ordinary Profits, and Net Profits
FY2023 1Q Financial Results (4) Non-operating Income (Expenses), Ordinary Profits, and Net Profits FY2022 FY2023 Increase/Decrease [Non-operating income] (Millions of yen) 1st quarter 1st quarter (Amount) (%) ●72 million yen increase in interest income from Net sales 43,739 47,015 +3,275 +7.5% inves
Slide 8: Table of Contents
Table of Contents 1. Financial Results for the First Quarter of FY 2023 2. Shift to management based on cost of capital 3. Initiative for Sustainable Growth ・New model plant to support sustainable growth ・Expansion of pharmaceutical business 4. First Quarter Topics ・Integrated Report 2023 ・Environme
Slide 9: Shift to management based on cost of capital (Analysis of Present State)
2. Shift to management based on cost of capital (Analysis of Present State) From 2021 onward PBR is continuously less than 1. ROE has exceeded cost of shareholder's equity yet seeing down trend. PBR 2,000 2.5 PER Future Sustainable Growth Vision 2.4 Although the current medium-term 1,500 2.0 managem
Slide 10: Shift to management based on cost of capital (Subjects & Actions)
2. Shift to management based on cost of capital (Subjects & Actions) Setting ROE as an important management indicator, we will address the three challenges of sustainable growth, capital efficiency and financial leverage. Target early realization of PBR more than 1. Target figures and planned milest
Slide 11: Shift to management based on cost of capital (Our Business Solving Image)
2. Shift to management based on cost of capital (Our Business Solving Image) Current Future Slow correspondence to change Speed up our correspondence to change and further review our business portfolio to improve Future Sustainable Growth capital efficiency and achieve sustainable growth. Although t
Slide 12: Table of Contents
Table of Contents 1. Financial Results for the First Quarter of FY 2023 2. Shift to management based on cost of capital 3. Initiative for Sustainable Growth ・New model plant to support sustainable growth ・Expansion of pharmaceutical business 4. First Quarter Topics ・Integrated Report 2023 ・Environme
Slide 13: Initiative for Sustainable Growth: Sustainable Growth Strategy
3. Initiative for Sustainable Growth : Sustainable Growth Strategy Creation of a new business ・Cultivate start-up businesses that will model that leads to the next become future core business generation Sustainable Business Growth ・Expand business areas by Pharmaceutical Expansion of product market
Slide 14: New model plant to support sustainable growth
Expansion of product market and target area Steadily reinforce 4 existing 3. New model plant to support sustainable growth businesses Expansion of product market and target area We plan to make a concentrated investment in “Primary Packaging Business" which is pointed as growth business. Investment
Slide 15: Expansion of pharmaceutical business
Expansion of product 3. Expansion of pharmaceutical business market and target area ⚫ We will leverage our existing technologies and networks to develop our packaging business in the growing pharmaceuticals market and grow it into a new pillar of our business. 1 Billion USD 【Market Background】 Other
Slide 16: Policies for Japan: Accelerate Imported Biopharmaceutical Packaging CMO Business ①
Expansion of product 3. Expansion of Pharmaceutical Business： market and target area Policies for Japan Accelerate Imported Biopharmaceutical Packaging CMO Business ① ⚫ Acquired stock of Toride Pharma K.K. and its asset management company TAT Toride Asset Trading K.K. on 1 June 2023. Name Toride Pha
Slide 17: Policies for Japan: Accelerate Imported Biopharmaceutical Packaging CMO Business ②
Expansion of product 3.Expansion of Pharmaceutical Business： market and target area Policies for Japan Accelerate Imported Biopharmaceutical Packaging CMO Business ② Conventional CDMO contract model: Integrated Contract from formulation development to packaging and delivery. Our Packaging CMO busine
Slide 18: Policies for overseas: Machinery for Pharmaceutical Industry
Expansion of product 3．Expansion of Pharmaceutical Business： market and target area Policies for overseas Machinery for Pharmaceutical Industry Focus on developing and selling differentiated labelling machine for Auto Injector which is growing fast in the market. ● Purchased land of 15,700㎡ next to
Slide 19: Table of Contents
Table of Contents 1. Financial Results for the First Quarter of FY 2023 2. Shift to management based on cost of capital 3. Initiative for Sustainable Growth ・New model plant to support sustainable growth ・Expansion of pharmaceutical business 4. First Quarter Topics ・Integrated Report 2023 ・Environme
Slide 20: Integrated Report 2023
4. Integrated Report 2023 ■ Positioning of the Integrated Report Financial Information Non-Financial Information Security Report Corporate Governance Report NEW Environment Financial Reports Report IR Information site Sustainability Information site NEW Integrated Report ■ Content of Integrated Repo
Slide 21: Environmental Initiatives: Shrink Sleeve Label
4. Environmental Initiatives： Shrink Sleeve Label Label to Label（ PIR： Post Industrial Recycling） Last year in 2022, Kagome Co., Ltd. adopted our shrink sleeve labels made of recycled materials derived from labels. As the second phase of the project, shrink labels made from recycled materials derive
Slide 22: Environmental Initiatives: Primary packaging Pouches ①
Environmental Initiatives : Example : Primary packaging Pouches① Pouch to Pouch Kao Corporation and Lion Corporation has launched refill spouted pouch for a limited quantity partially containing recycled material. 10% of recycled material is used in these products. In each production process, we hav
Slide 23: Environmental Initiatives: Primary packaging Pouches ②
Environmental Initiatives : Example : Primary packaging Pouches② Mono-material pouches Fuji Seal Group has been working with Kimura Soap Co., Ltd. and G-Place Corporation on the project of spouted pouch recycling where spouted pouches were collected after use from consumers. *As a result of the coop
Slide 24: Environmental Initiatives: Primary packaging Pouches ③
Environmental Initiatives : Example : Primary packaging Pouches③ Packages to something valuable As a way to utilize waste materials that are difficult to Horizontal recycle, we are working on recycling other than packaging. We have been working with building materials manufacturers Joto Techno Co.,
Slide 25: Our Vision
Our Vision Copyright 2023 Fuji Seal Group 25
Slide 26: Cautionary Statement
Cautionary Statement This report is intended to provide a better understanding of the Fuji Seal Group and is not necessarily intended to recommend investment. This report includes earnings forecasts and business plans, which are based on certain assumptions in the economic environment and business p
Fuji Seal International — Q1 FY2023 Earnings Presentation on 6ix